Vietnam Begins First Human Trials Of Bird Flu Vaccine
This article was originally published in PharmAsia News
Vietnam researchers began the first human test of a locally developed bird flu vaccine, beginning with 24 military students. The Phase I trial is being conducted by the Military Medical Institute, which plans two inoculations of the participants, 28 days apart. The H5N1 vaccine was developed by the Vaccine and Bio-Technology Products Company No. 1, which already has produced 100,000 doses and is prepared to mass-produce the vaccine by the middle of next year if the trials prove successful. (Click here for more
You may also be interested in...
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.